ONESOURCE SPECIALTY PHARMA LIMITED

ONESOURCE SPECIALTY PHARMA LIMITED (India) is linked to 1 FDA-registered manufacturing site. 23 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “ONESOURCE SPECIALTY PHARMA LIMITED: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/onesource-specialty-pharma-limited

Overview

Stelis Biopharma Limited is a fully integrated biopharmaceutical company based in India, specializing in end-to-end solutions from development to commercial manufacturing of biologics and biosimilars. It operates as a subsidiary of Strides Pharma Science Limited.

Core services & business areas

Biologics ManufacturingFormulation DevelopmentProcess DevelopmentFill and FinishAnalytical Development

Therapeutic areas

BiologicsBiosimilarsCell & Gene Therapy

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to ONESOURCE SPECIALTY PHARMA LIMITED, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

23 FDA enforcement records linked to this company.

  • recall — Class II2026-07-15

    Failed Impurities/Degradation Specifications

  • 4832026-06-30

    Procedures for sterile drug products

  • 4832025-03-28

    Absence of Written Procedures

  • 4832025-03-28

    Validation lacking for sterile drug products

  • 4832025-03-28

    Procedures for sterile drug products

  • 4832025-03-28

    Environmental Monitoring System

  • 4832024-03-28

    Representative Samples

  • 4832024-03-28

    Procedures for sterile drug products

  • 4832024-03-28

    Training , Education , Experience overall

  • 4832024-03-28

    Record maintenance 1 year (except exempt OTC)

  • 4832024-03-28

    Procedures not in writing, fully followed

  • 4832024-03-28

    No written record of investigation

  • 4832024-03-28

    Failing drug products not rejected

  • 4832024-03-28

    Acceptance of drug products

  • 4832019-12-20

    Investigations of discrepancies, failures

  • 4832019-02-14

    Equipment Design, Size and Location

  • 4832018-03-13

    Representative Samples

  • 4832018-03-13

    Procedures for sterile drug products

  • 4832018-03-13

    Control procedures to monitor and validate performance

  • 4832018-03-13

    Written record of investigation incomplete

  • warning_letter2015-08-07

    FDA Warning Letter (drug product)

  • 4832011-09-29

    In-process materials specifications testing

  • 4832011-09-29

    Investigations of discrepancies, failures

For suppliers

Is this ONESOURCE SPECIALTY PHARMA LIMITED?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.